Form 4: HealthStream Inc. Executive Jeff Cunningham Reports Stock Transactions
SEC Form 4 Filing
HealthStream's Chief Technology Officer, Jeff Cunningham, reports acquisition of shares through vesting of restricted share units and subsequent disposal for tax liability.
Summary
- Jeff Cunningham, Chief Technology Officer of HealthStream Inc. (HSTM), filed a Form 4 detailing changes in beneficial ownership.
- On September 27, 2024, Cunningham acquired 422 shares of common stock upon the vesting of restricted share units (RSUs).
- Simultaneously, 103 shares were disposed of to cover tax liabilities at a price of $28.31 per share.
- Following these transactions, Cunningham directly owns 25,600 shares of HealthStream Inc.
- Cunningham also holds 2,390 restricted share units.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing reflecting standard executive compensation practices. The acquisition through vesting is mildly positive, offset by the sale for tax purposes.
Positives
- The acquisition of shares through RSU vesting indicates confidence in the company's future performance.
Negatives
- The disposal of shares to cover tax liabilities, while common, slightly reduces Cunningham's holdings.
Risks
- Future vesting schedules and potential tax implications could lead to further changes in Cunningham's holdings.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedule of RSUs suggests continued service and potential future acquisitions of shares.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions, which are closely monitored by investors for signals about a company's prospects.
Comparison to Industry Standards
- Executive compensation packages often include RSUs as a way to align management's interests with those of shareholders.
- Vesting schedules are common and typically span several years to incentivize long-term commitment.
- Similar companies like Cerner (now Oracle Health) and Allscripts also utilize RSUs in their executive compensation plans.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 09/20/2024 | 15% of RSUs vest |
| 09/27/2024 | Acquisition of 422 shares through RSU vesting and disposal of 103 shares for tax liability |
| 09/20/2025 | 20% of RSUs vest |
| 09/20/2026 | 30% of RSUs vest |
| 09/20/2027 | 35% of RSUs vest |
| 10/01/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.